Education/Credentials: Ohio University and Xavier University (Natural Sciences) Contact Information Medical Sciences Building 1459 Office 513-558-0736 Email schmidnm@ucmail.uc.edu Peer Reviewed Publications Sadaka, Basma; Ejaz, Nicole S; Shields, Adele R; Cardi, Michael A; Wadih, George; Witte, David; Abu Jawdeh, Bassam G; Alloway, Rita R; Woodle, E Steve 2015. A Banff Component Scoring-based Histologic Assessment of Bortezomib-based Antibody-mediated Rejection Therapy. Transplantation, 99 8, 1691-9Ejaz, Nicole S; Alloway, Rita R; Halleck, Fabian; Dürr, Michael; Budde, Klemens; Woodle, E Steve 2014. Review of bortezomib treatment of antibody-mediated rejection in renal transplantation. Antioxidants & redox signaling, 21 17, 2401-18Heaton, Pamela; Tundia, Namita L; Schmidt, Nicole; Wigle, Patricia R; Kelton, Christina M L 2013. Authors' response. Journal of pediatric gastroenterology and nutrition, 56 2, e12Woodle, E Steve; Alloway, Rita R; Ejaz, Nicole Schmidt 2013. Plasma cell biology: principles for therapeutic design. Clinical transplants, , 277-83Heaton, Pamela C; Tundia, Namita L; Schmidt, Nicole; Wigle, Patricia R; Kelton, Christina M L 2012. National burden of pediatric hospitalizations for inflammatory bowel disease: results from the 2006 Kids' Inpatient Database. Journal of pediatric gastroenterology and nutrition, 54 4, 477-85Sadaka, Basma; Alloway, Rita R; Shields, Adele R; Schmidt, Nicole M; Woodle, E Steve 2012. Proteasome inhibition for antibody-mediated allograft rejection. Seminars in hematology, 49 3, 263-9Schmidt, Nicole; Alloway, Rita R; Walsh, R Carlin; Sadaka, Basma; Shields, Adele R; Girnita, Alin L; Hanseman, Dennis J; Woodle, E Steve 2012. Prospective evaluation of the toxicity profile of proteasome inhibitor-based therapy in renal transplant candidates and recipients. Transplantation, 94 4, 352-61Ejaz N.;Shields A.;Alloway R.;Sadaka B.;Girnita A.;Mogilishetty G.;Cardi M.;Woodle E. 12-01-2013. Randomized controlled pilot study of B cell-targeted induction therapy in HLA sensitized kidney tran American Journal of Transplantation, 13 12, 3142-3154Woodle E.;Shields A.;Ejaz N.;Sadaka B.;Girnita A.;Walsh R.;Alloway R.;Brailey P.;Cardi M.;Abu Jawdeh B.;Roy-Chaudhury P.;Govil A.;Mogilishetty G. 01-01-2015. Prospective iterative trial of proteasome inhibitor-based desensitization American Journal of Transplantation, 15 1, 101-118
Peer Reviewed Publications Sadaka, Basma; Ejaz, Nicole S; Shields, Adele R; Cardi, Michael A; Wadih, George; Witte, David; Abu Jawdeh, Bassam G; Alloway, Rita R; Woodle, E Steve 2015. A Banff Component Scoring-based Histologic Assessment of Bortezomib-based Antibody-mediated Rejection Therapy. Transplantation, 99 8, 1691-9Ejaz, Nicole S; Alloway, Rita R; Halleck, Fabian; Dürr, Michael; Budde, Klemens; Woodle, E Steve 2014. Review of bortezomib treatment of antibody-mediated rejection in renal transplantation. Antioxidants & redox signaling, 21 17, 2401-18Heaton, Pamela; Tundia, Namita L; Schmidt, Nicole; Wigle, Patricia R; Kelton, Christina M L 2013. Authors' response. Journal of pediatric gastroenterology and nutrition, 56 2, e12Woodle, E Steve; Alloway, Rita R; Ejaz, Nicole Schmidt 2013. Plasma cell biology: principles for therapeutic design. Clinical transplants, , 277-83Heaton, Pamela C; Tundia, Namita L; Schmidt, Nicole; Wigle, Patricia R; Kelton, Christina M L 2012. National burden of pediatric hospitalizations for inflammatory bowel disease: results from the 2006 Kids' Inpatient Database. Journal of pediatric gastroenterology and nutrition, 54 4, 477-85Sadaka, Basma; Alloway, Rita R; Shields, Adele R; Schmidt, Nicole M; Woodle, E Steve 2012. Proteasome inhibition for antibody-mediated allograft rejection. Seminars in hematology, 49 3, 263-9Schmidt, Nicole; Alloway, Rita R; Walsh, R Carlin; Sadaka, Basma; Shields, Adele R; Girnita, Alin L; Hanseman, Dennis J; Woodle, E Steve 2012. Prospective evaluation of the toxicity profile of proteasome inhibitor-based therapy in renal transplant candidates and recipients. Transplantation, 94 4, 352-61Ejaz N.;Shields A.;Alloway R.;Sadaka B.;Girnita A.;Mogilishetty G.;Cardi M.;Woodle E. 12-01-2013. Randomized controlled pilot study of B cell-targeted induction therapy in HLA sensitized kidney tran American Journal of Transplantation, 13 12, 3142-3154Woodle E.;Shields A.;Ejaz N.;Sadaka B.;Girnita A.;Walsh R.;Alloway R.;Brailey P.;Cardi M.;Abu Jawdeh B.;Roy-Chaudhury P.;Govil A.;Mogilishetty G. 01-01-2015. Prospective iterative trial of proteasome inhibitor-based desensitization American Journal of Transplantation, 15 1, 101-118
Sadaka, Basma; Ejaz, Nicole S; Shields, Adele R; Cardi, Michael A; Wadih, George; Witte, David; Abu Jawdeh, Bassam G; Alloway, Rita R; Woodle, E Steve 2015. A Banff Component Scoring-based Histologic Assessment of Bortezomib-based Antibody-mediated Rejection Therapy. Transplantation, 99 8, 1691-9Ejaz, Nicole S; Alloway, Rita R; Halleck, Fabian; Dürr, Michael; Budde, Klemens; Woodle, E Steve 2014. Review of bortezomib treatment of antibody-mediated rejection in renal transplantation. Antioxidants & redox signaling, 21 17, 2401-18Heaton, Pamela; Tundia, Namita L; Schmidt, Nicole; Wigle, Patricia R; Kelton, Christina M L 2013. Authors' response. Journal of pediatric gastroenterology and nutrition, 56 2, e12Woodle, E Steve; Alloway, Rita R; Ejaz, Nicole Schmidt 2013. Plasma cell biology: principles for therapeutic design. Clinical transplants, , 277-83Heaton, Pamela C; Tundia, Namita L; Schmidt, Nicole; Wigle, Patricia R; Kelton, Christina M L 2012. National burden of pediatric hospitalizations for inflammatory bowel disease: results from the 2006 Kids' Inpatient Database. Journal of pediatric gastroenterology and nutrition, 54 4, 477-85Sadaka, Basma; Alloway, Rita R; Shields, Adele R; Schmidt, Nicole M; Woodle, E Steve 2012. Proteasome inhibition for antibody-mediated allograft rejection. Seminars in hematology, 49 3, 263-9Schmidt, Nicole; Alloway, Rita R; Walsh, R Carlin; Sadaka, Basma; Shields, Adele R; Girnita, Alin L; Hanseman, Dennis J; Woodle, E Steve 2012. Prospective evaluation of the toxicity profile of proteasome inhibitor-based therapy in renal transplant candidates and recipients. Transplantation, 94 4, 352-61Ejaz N.;Shields A.;Alloway R.;Sadaka B.;Girnita A.;Mogilishetty G.;Cardi M.;Woodle E. 12-01-2013. Randomized controlled pilot study of B cell-targeted induction therapy in HLA sensitized kidney tran American Journal of Transplantation, 13 12, 3142-3154Woodle E.;Shields A.;Ejaz N.;Sadaka B.;Girnita A.;Walsh R.;Alloway R.;Brailey P.;Cardi M.;Abu Jawdeh B.;Roy-Chaudhury P.;Govil A.;Mogilishetty G. 01-01-2015. Prospective iterative trial of proteasome inhibitor-based desensitization American Journal of Transplantation, 15 1, 101-118